UAE, UNFILTERED
01
Why it matters
M42/Abu Dhabi Biobank partnership with BioTwin to expand Virtual Human Twin technology using UAE health and biological data.
AI
ROBIUS / AI ECOSYSTEM PROFILE
Abu Dhabi Biobank–BioTwin Virtual Human Twin
digital-twin-health-platformstrategic-partnershipFresh
Last independently checkedSeptember 23, 2026Checked 37 days ago.
THE ROBIUS VIEW
Select assessment
M42/Abu Dhabi Biobank partnership with BioTwin to expand Virtual Human Twin technology using UAE health and biological data.
DECISION BRIEF
What this record means
A concise reading of the structured evidence, written for practical decision-making.
02
Who can use or is affected
Strategic life-sciences programme announced July 2026.
03
What to watch next
The July 2026 source confirms an M42/Abu Dhabi Biobank–BioTwin strategic partnership to expand Virtual Human Twin technology in the UAE. This is distinct from BioTwin's earlier Cleveland Clinic Abu Dhabi breast-cancer screening pilot and should not be presented as population-scale clinical validation.
Evidence strengthNeeds review
Important evidence or freshness checks are incomplete.
Last checkedSeptember 23, 2026
Next reviewNovember 7, 2026
EVIDENCE CHECK
How the assessment is supported
- Primary evidence linked1 official source is attached.
- Freshness checkChecked 37 days ago.
- Editorial publication gateThis public version passed the system publication requirements.
- Material changes preservedNo material update has been recorded after the baseline.
01
Primary sourceLinked evidence on mediaoffice.abudhabi
02
Editorial checkReviewed September 23, 2026
03
Next triggerRoutine evidence refresh
RELATIONSHIP INTELLIGENCE
How this record connects
Explore editorially mapped links, inbound connections and clearly labelled context derived from the published record.
ECOSYSTEM RECORD
What the evidence currently shows
verified
Abu Dhabi
Healthcare
Virtual human twins; AI; biobank data; precision medicine; predictive health.
Uses multimodal biological and health data to build virtual human representations for predictive and personalised research.
strategic-partnership
M42 announced a strategic partnership between Abu Dhabi Biobank and BioTwin during Abu Dhabi's July 2026 US health mission.
Future research and clinical partners; no consumer deployment claimed.
M42 / Abu Dhabi Biobank + BioTwin.
Strategic life-sciences programme announced July 2026.
SOURCE RECORD
Official information
Official links let readers inspect the evidence directly. Marketing descriptions are not treated as proof of deployment, customers, performance, or availability.
SIDE-BY-SIDE
Compare intelligence records
Compare like-for-like fields within this Intelligence system. Empty fields remain clearly marked rather than guessed.
Choose a record to begin.The comparison will use the same structured fields that power the public profiles.
RECORD HISTORY
How this intelligence evolved
Material editorial changes are preserved so readers can see when and why the public record moved.
- Evidence reviewSource checked
The supporting evidence was reviewed.
Robius checked the linked primary source and preserved the current public assessment.
- Public baselinePublished record
The first verified public version was established.
Later material edits appear above this baseline. Routine formatting changes are not shown.
No commercial relationship is recorded for this profile. Commercial relationships cannot change the Robius assessment or omission of material limitations.